Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Enovis
ENOV
$1.56B
| – | – |
-6,909
| Closed | -$848K |
|
|
EXAS
727
DELISTED
Exact Sciences
EXAS
| – | – |
-126,273
| Closed | -$1.79M |
|
728
FTI Consulting
FCN
$4.9B
| – | – |
-12,874
| Closed | -$429K |
|
729
Genpact
G
$5.24B
| – | – |
-18,234
| Closed | -$318K |
|
730
Green Dot
GDOT
$760M
| – | – |
-15,094
| Closed | -$295K |
|
731
The GEO Group
GEO
$3.94B
| – | – |
-2,068,596
| Closed | -$44.5M |
|
732
Hilton Worldwide
HLT
$73.1B
| – | – |
-114,743
| Closed | -$7.66M |
|
733
IBM
IBM
$200B
| – | – |
-19,996
| Closed | -$3.68M |
|
734
PUT
Incyte
INCY
$23.4B
| – | – |
-500,000
| Closed | -$26.8M |
|
735
Inovio Pharmaceuticals
INO
$92.1M
| – | – |
-26,042
| Closed | -$4.16M |
|
736
IQVIA
IQV
$34.4B
| – | – |
-99,360
| Closed | -$5.04M |
|
737
PUT
iShares Russell 2000 ETF
IWM
$81.7B
| – | – |
-1,000,000
| Closed | -$116M |
|
738
Jefferies Financial Group
JEF
$12.7B
| – | – |
-35,617
| Closed | -$893K |
|
739
Liquidity Services
LQDT
$1.23B
| – | – |
-589,724
| Closed | -$15.4M |
|
740
Southwest Airlines
LUV
$23.5B
| – | – |
-73,298
| Closed | -$1.73M |
|
741
LyondellBasell Industries
LYB
$19.1B
| – | – |
-22,156
| Closed | -$1.97M |
|
742
Neurogene
NGNE
$744M
| – | – |
-3,750
| Closed | -$955K |
|
743
Oceaneering
OII
$4.22B
| – | – |
-13,833
| Closed | -$994K |
|
744
Polaris
PII
$4.16B
| – | – |
-2,270
| Closed | -$317K |
|
|
PRO
745
DELISTED
PROS Holdings
PRO
| – | – |
-11,564
| Closed | -$364K |
|
746
PTC
PTC
$14.4B
| – | – |
-7,737
| Closed | -$274K |
|
747
PTC Therapeutics
PTCT
$6.52B
| – | – |
-861,826
| Closed | -$22.5M |
|
748
Raymond James Financial
RJF
$32.8B
| – | – |
-8,643
| Closed | -$322K |
|
|
SCHW
749
Charles Schwab
SCHW
$177B
| – | – |
-1,084,561
| Closed | -$29.6M |
|
750
Sprouts Farmers Market
SFM
$7.13B
| – | – |
-2,111,324
| Closed | -$76.1M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.